Sanofi (SNY)
NASDAQ: SNY · IEX Real-Time Price · USD
48.56
-0.12 (-0.24%)
May 20, 2024, 1:12 PM EDT - Market open
Sanofi Employees
Sanofi had 86,088 employees on December 31, 2023. The number of employees decreased by 5,485 or -5.99% compared to the previous year.
Employees
86,088
Change (1Y)
-5,485
Growth (1Y)
-5.99%
Revenue / Employee
$599,438
Profits / Employee
$69,696
Market Cap
111.18B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
Dec 31, 2020 | 99,412 | -997 | -0.99% |
Dec 31, 2019 | 100,409 | -3,817 | -3.66% |
Dec 31, 2018 | 104,226 | -2,340 | -2.20% |
Dec 31, 2017 | 106,566 | -293 | -0.27% |
Dec 31, 2016 | 106,859 | -2,230 | -2.04% |
Dec 31, 2015 | 109,089 | 1,702 | 1.58% |
Dec 31, 2014 | 107,387 | -4,741 | -4.23% |
Dec 31, 2013 | 112,128 | 154 | 0.14% |
Dec 31, 2012 | 111,974 | -1,745 | -1.53% |
Dec 31, 2011 | 113,719 | 12,144 | 11.96% |
Dec 31, 2010 | 101,575 | -3,292 | -3.14% |
Dec 31, 2009 | 104,867 | 6,654 | 6.78% |
Dec 31, 2008 | 98,213 | -1,282 | -1.29% |
Dec 31, 2007 | 99,495 | -794 | -0.79% |
Dec 31, 2006 | 100,289 | 3,108 | 3.20% |
Dec 31, 2005 | 97,181 | 742 | 0.77% |
Dec 31, 2004 | 96,439 | 63,353 | 191.48% |
Dec 31, 2003 | 33,086 | 650 | 2.00% |
Dec 31, 2002 | 32,436 | 1,922 | 6.30% |
Dec 31, 2001 | 30,514 | 1,314 | 4.50% |
Dec 31, 2000 | 29,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Elevance Health | 104,900 |
Medtronic | 95,000 |
Cigna | 72,500 |
GSK | 70,212 |
Boston Scientific | 48,000 |
Bristol-Myers Squibb Company | 34,100 |
Stryker | 26,700 |
Intuitive Surgical | 13,676 |
SNY News
- 5 hours ago - Shah Capital ends campaign against Novavax board after Sanofi deal - Reuters
- 6 days ago - Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker - CNBC
- 7 days ago - Sanofi to Spend $1 Billion to Boost Drug Production in France - WSJ
- 7 days ago - Sanofi pledges new 1 bln euros worth of investments in French production sites - Reuters
- 7 days ago - Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty - GlobeNewsWire
- 10 days ago - Novavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines - Investopedia
- 10 days ago - Novavax Gets $1.4 Billion Deal With Sanofi. The Stock Jumps. - Barrons
- 10 days ago - Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses - Invezz